Literature DB >> 464746

Multimodality treatment. A one-year follow-up of 84 hyperactive boys.

J H Satterfield, D P Cantwell, B T Satterfield.   

Abstract

This study reports findings at the end of the first year of a three-year prospective study of 84 hyperactive boys. A multidimensional approach to evaluation and an individualized multimodality treatment plan commensurate with each child's disabilities was used. Treatment plans were implemented by members of the research staff working together as a coordinated therapeutic team. Measures of the child's behavior at home and at school, academic performance, delinquent behavior, and emotional adjustment were obtained initially and at one year. Results suggest that the combination of a clinically useful medication with appropriate psychological treatments simultaneously directed to each of the child's many disabilities is associated with an unexpectedly good outcome. Whether this will continue to be true when these children are followed up over a longer period of time awaits further investigation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 464746     DOI: 10.1001/archpsyc.1979.01780090051006

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  5 in total

1.  Psychiatry-epitomes of progress: hyperkinetic behavior disorder.

Authors:  J H Satterfield
Journal:  West J Med       Date:  1981-02

2.  A review of long-acting medications for ADHD in Canada.

Authors:  Sheik Hosenbocus; Raj Chahal
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2009-11

Review 3.  Current concepts and controversies in the diagnosis and treatment of attention deficit hyperactivity disorder.

Authors:  P S Jensen
Journal:  Curr Psychiatry Rep       Date:  2000-04       Impact factor: 5.285

4.  Hyperactivity: nature of the syndrome and its natural history.

Authors:  M G Aman
Journal:  J Autism Dev Disord       Date:  1984-03

5.  Pills or skills for hyperactive children.

Authors:  K D O'Leary
Journal:  J Appl Behav Anal       Date:  1980
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.